TrialPloS one2019

Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.

Mitsuhide Naruse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.